Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related USG
Wall Street's M&A Chatter From November 14: iRobot, USG-Ceiling Plus, Match Group-Bumble
Jim Cramer Advises His Viewers On Activision Blizzard, Priceline And More
Related FHN
Benzinga's Top Upgrades, Downgrades For November 8, 2017
This Millennial Trader Pinpoints Customer Service As A Key Sign Of Company Longevity

Analysts at Credit Suisse upgraded USG (NYSE: USG) from “underperform” to “neutral.” The target price for USG has been raised from $22 to $27. USG's stock closed at $24.55 on Friday.

Analysts at Compass Point upgraded First Horizon National (NYSE: FHN) from “sell” to “neutral.” The target price for First Horizon National has been raised from $9.50 to $10. First Horizon National's shares closed at $9.90 on Friday.

JP Morgan upgraded Perrigo Company (NASDAQ: PRGO) from “neutral” to “overweight.” The target price for Perrigo has been raised from $120 to $132. Perrigo's shares closed at $119.47 on Friday.

Morgan Stanley upgraded AbbVie (NYSE: ABBV) from “equal weight” to “overweight.” The target price for AbbVie has been raised from $36 to $49. AbbVie's shares closed at $42.39 on Friday.

Latest Ratings for USG

DateFirmActionFromTo
Nov 2017JP MorganMaintainsNeutral
Oct 2017BarclaysMaintainsEqual-Weight
Oct 2017Bank of AmericaDowngradesNeutralUnderperform

View More Analyst Ratings for USG
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (FHN + ABBV)

View Comments and Join the Discussion!

Partner Center